30 likes | 154 Views
A novel replication-competent modified vaccinia Tiantan (MVTT)-based HIV Vaccine Haibo Wang 1, 2 , Linqi Zhang 3 and Zhiwei Chen 1 1 AIDS Institute, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, PR. China;
E N D
A novel replication-competent modified vaccinia Tiantan (MVTT)-based HIV Vaccine Haibo Wang1, 2, Linqi Zhang3 and Zhiwei Chen1 1 AIDS Institute, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, PR. China; 2 Zhuhai International Travel Healthcare Center, Zhuhai, 519020, PR China; 3 Comprehensive AIDS Research Center and Research Center for Public Health, School of Medicine, Tsinghua University, Beijing, 100084, PR China Advantages of MVTT: Patented live replicating viral vector(Virology 2005); Immunogenic than MVA (PLoS One 2009); Highly attenuated and safe in SCID mice(Vaccine 2010); Protective immunity(JVI 2013). Problems: Instability of foreign genes; Screening process.
In vitro characterization p3F p2F p4F p1F A D gag-pol env p1R p2R p4R p3R 1 2 3 4 5 6 7 8 9 10 11 12 13 14 E Template: 1,4,8,12 MVTTHKU-gpe/AE13; 2,5,9,13 MVTT; 3,6,10,14 Blank. Lane 1-3: primer set 1, indicating the large deletion site on the genome. Lane 4-6: primer set 2, indicating the insertion of env. Lane 8-10: primer set 3, indicating the insertion of gag. Lane 12-14: primer set 4, indicating the insertion of pol. B C MVTT M MVTTHKU-gpe/AE13 Gag-pol P1 Env P6 Pol Gag MVTT MVTTHKU-gpe/AE13
In vivo characterization A B Conclusion • We have constructed a novel MVTT-based HIV vaccine to express env and gag-pol genes of HIVCRF01_AE. • This vaccine remainsreplication-competentwith excellent transgene stability. • The vaccine displays satisfactory safety and immunogenicity profiles in small animals. • Non-human primates studies and human trials have been planned to further characterize its immunogenicity. • Given the success (although modest) of RV144 trial, we believe this novel replication-competent modified vaccinia Tiantan-based vaccine will play a key role during the combating of HIV/AIDS pandemic. We thank HK-RGC762811, HKU-UDF and China’s Mega Project 2012ZX10001-009 for support.